Profound Medical (NASDAQ:PROF – Get Free Report) and Owlet (NYSE:OWLT – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Profound Medical and Owlet, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Profound Medical | 1 | 0 | 1 | 1 | 2.67 |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
Profound Medical presently has a consensus target price of $11.50, indicating a potential upside of 54.99%. Owlet has a consensus target price of $15.00, indicating a potential upside of 337.19%. Given Owlet’s higher possible upside, analysts clearly believe Owlet is more favorable than Profound Medical.
Earnings & Valuation
This table compares Profound Medical and Owlet”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Profound Medical | $16.10 million | 16.88 | -$42.57 million | ($0.93) | -7.98 |
| Owlet | $105.70 million | 0.95 | -$39.68 million | ($0.75) | -4.57 |
Owlet has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
47.9% of Profound Medical shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 36.2% of Owlet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Profound Medical and Owlet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Profound Medical | -137.51% | -59.57% | -47.87% |
| Owlet | -8.61% | -601.24% | -15.96% |
Volatility and Risk
Profound Medical has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Owlet has a beta of 2.17, indicating that its stock price is 117% more volatile than the S&P 500.
Summary
Owlet beats Profound Medical on 11 of the 15 factors compared between the two stocks.
About Profound Medical
Profound Medical Corp. is a Canadian medical-device company that develops MRI-guided therapies using focused ultrasound. Its systems combine magnetic resonance imaging with ultrasound energy to help clinicians target and treat tissue without conventional open surgery. The company’s TULSA-PRO system is designed to ablate prostate tissue. It also offers Sonalleve, an MRI-guided focused-ultrasound platform developed for applications including the treatment of uterine fibroids and the palliation of pain from bone metastases.
About Owlet
Owlet develops connected baby-monitoring products designed to give parents information about an infant’s sleep and well-being. Its offerings include the Dream Sock, a wearable monitor that tracks sleep-related readings, and Owlet Cam cameras, which provide video and audio monitoring through the company’s app. The company’s products combine wearable sensors, cameras and mobile software to help families monitor their babies at home. The Dream Sock has FDA clearance to monitor pulse rate and oxygen saturation in infants from 1 to 18 months of age.
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.
